CorVel (NASDAQ:CRVL) Share Price Crosses Below 200 Day Moving Average – Should You Sell?

CorVel Corp. (NASDAQ:CRVL)’s stock price crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $81.10 and traded as low as $69.84. CorVel shares last traded at $71.42, with a volume of 242,487 shares traded.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CRVL shares. Weiss Ratings reaffirmed a “hold (c)” rating on shares of CorVel in a research report on Tuesday, October 14th. Wall Street Zen cut CorVel from a “buy” rating to a “hold” rating in a research note on Saturday, November 8th. One research analyst has rated the stock with a Hold rating, According to MarketBeat.com, the stock currently has an average rating of “Hold”.

CorVel Price Performance

The firm has a market cap of $3.66 billion, a price-to-earnings ratio of 35.18 and a beta of 1.07. The stock’s fifty day moving average price is $71.38 and its 200-day moving average price is $80.94.

CorVel (NASDAQ:CRVL) last posted its earnings results on Tuesday, November 4th. The business services provider reported $0.54 earnings per share (EPS) for the quarter. CorVel had a net margin of 11.28% and a return on equity of 31.72%. The firm had revenue of $239.64 million during the quarter.

Insider Activity at CorVel

In other CorVel news, Director R Judd Jessup sold 7,076 shares of CorVel stock in a transaction on Tuesday, November 11th. The stock was sold at an average price of $76.94, for a total value of $544,427.44. Following the completion of the transaction, the director owned 115,045 shares in the company, valued at approximately $8,851,562.30. The trade was a 5.79% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, EVP Mark E. Bertels sold 1,200 shares of the business’s stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an average price of $72.35, for a total transaction of $86,820.00. Following the completion of the transaction, the executive vice president owned 2,594 shares of the company’s stock, valued at $187,675.90. This trade represents a 31.63% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders sold 11,733 shares of company stock valued at $894,686. Insiders own 44.56% of the company’s stock.

Institutional Investors Weigh In On CorVel

Hedge funds have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of CorVel by 0.7% during the second quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,961 shares of the business services provider’s stock valued at $1,640,000 after acquiring an additional 115 shares during the last quarter. The Manufacturers Life Insurance Company lifted its stake in CorVel by 0.9% in the second quarter. The Manufacturers Life Insurance Company now owns 15,918 shares of the business services provider’s stock valued at $1,636,000 after buying an additional 139 shares during the period. Arizona State Retirement System lifted its position in shares of CorVel by 1.7% during the 3rd quarter. Arizona State Retirement System now owns 9,113 shares of the business services provider’s stock valued at $706,000 after acquiring an additional 155 shares during the period. Atria Investments Inc grew its holdings in CorVel by 1.3% in the second quarter. Atria Investments Inc now owns 14,646 shares of the business services provider’s stock worth $1,505,000 after purchasing an additional 186 shares during the period. Finally, ProShare Advisors LLC raised its holdings in shares of CorVel by 3.0% during the second quarter. ProShare Advisors LLC now owns 6,466 shares of the business services provider’s stock valued at $665,000 after purchasing an additional 189 shares during the period. 51.36% of the stock is currently owned by institutional investors and hedge funds.

CorVel Company Profile

CorVel Corporation (NASDAQ: CRVL) is a technology-driven provider of workers’ compensation, liability, and specialty risk management solutions. The company develops and deploys software and data analytics tools to streamline claims administration, medical cost containment, prescription drug management, and provider network access. CorVel’s integrated platform connects employers, insurers, healthcare providers, and injured workers, aiming to improve outcomes and control costs through process automation and real-time decision support.

The company’s product suite includes claims lifecycle management, bill review and negotiation, virtual care and telehealth services, pharmacy benefit management, and independent medical examinations (IMEs).